Radiopharm Theranostics (NasdaqCM:RADX) Update / briefing March 24, 2026 06:00 PM ET Company ParticipantsDimitris Voliotis - CMOHarshad Kulkarni - Chief Medical AdvisorRiccardo Canevari - Managing Director and CEORiccardo CanevariThanks a lot, Ben, and thanks to everybody for joining and for listening to us. We have decided to run this workshop after the press release of yesterday. A little bit of history. We were together mid-December when we reported the first interim analysis of the phase II-B trial of R ...